ClinicalTrials.Veeva

Menu

Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer

Zhejiang University logo

Zhejiang University

Status and phase

Enrolling
Phase 2
Phase 1

Conditions

Brain Metastases
Stage IV Non-small Cell Lung Cancer
Non Small Cell Lung Cancer

Treatments

Radiation: Hypofractionated Stereotactic Radiotherap

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The objective of this trial is to assess the safety and feasibility of delivering SBRT to patients with limited BMs (less than 10 lesions of lung cancer) by establishing the maximally tolerated dose (MTD) of SABR in 5 fractions.

Full description

The objective of this trial is to assess the safety and feasibility of delivering SBRT to patients with limited BMs (less than 10 lesions of lung cancer) by establishing the maximally tolerated dose (MTD) of SABR in 5 fractions.

Enrollment

21 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histology confirmed that it was non-small cell lung cancer
  • 1 to 10 brain metastases detected by magnetic resonance imaging (MRI)
  • A life expectancy of >3 months according to the DS GPA.
  • KPS ≥70
  • Control of the primary lesions (thorax) at the time of SBRT
  • 2cm<Tumor size ≤ 4 cm
  • Age of 18-75 years old
  • Patients must be able to undergo contrast enhanced MRI for planning
  • Adequate bone marrow and organ function

Exclusion criteria

  • other malignant tumors
  • Prior surgery to brain metastasis
  • Prior brain radiotherapy
  • Non-small cell lung cancer with more than 10 brain metastases detected by MRI
  • Contraindication to receiving radiotherapy.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

21 participants in 1 patient group

Hypofractionated Stereotactic Radiotherapy for Brain Metastases
Experimental group
Treatment:
Radiation: Hypofractionated Stereotactic Radiotherap

Trial contacts and locations

1

Loading...

Central trial contact

Bing Xia

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems